Teva stock jumps on Q1 earnings, successful trial results

  • 📰 YahooFinanceCA
  • ⏱ Reading Time:
  • 27 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 63%

Schizophrenia Treatment Notícia

Brasil Últimas Notícias,Brasil Manchetes

Teva Pharmaceutical (TEVA) stock is trading higher on Wednesday, following the company's beat in its first quarter earnings report. Contributing further to...

) stock is trading higher on Wednesday, following the company's beat in its first quarter earnings report. Contributing further to the rally, Teva unveiled encouraging results from a clinical study evaluating its Schizophrenia treatment, Olanzapine, driving shares higher.Let's talk about Teva as well.

Known as the Oracle of Omaha, Warren Buffett is one of the most successful investors of all time. He started his first investment partnership in 1956 with a few friends and family. An investment in...CALGARY — Suncor Energy Inc. says it is leasing and operating a number of Aframax oil tanker ships to carry crude from the recently completed Trans Mountain pipeline expansion to Pacific markets.

Nvidia will surge another 22%, and is still cheap compared to peers despite nearly doubling this year, Goldman Sachs says

 

Obrigado pelo seu comentário. Seu comentário será publicado após ser revisado.
Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

 /  🏆 47. in BR

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Report calls for changes to government’s interaction with drug-pricing board, pharmaceutical industryOther recommendations in the House of Commons report include a call for the government to spell out the mandate of the PMPRB and for Ottawa to review how it enacts drug price regulatory reforms
Fonte: globeandmail - 🏆 5. / 92 Consulte Mais informação »

Swiss pharmaceutical company Novartis to cut 680 jobs in product developmentAround 440 jobs will go in Switzerland and up to 240 in the United States over the next two to three years, the Basel-based company said
Fonte: globebusiness - 🏆 31. / 66 Consulte Mais informação »